Rowena Torres Inocencio

Rowena Inocencio practices at Incyte Pathology - Sacred Heart Medical Center Branch in Spokane, Washington.

Rowena Inocencio's NPI, 1548645088, was assigned on July 27, 2015. Rowena Inocencio holds Michigan license 4301108266.

Rowena Inocencio's primary practice is Incyte Pathology - Sacred Heart Medical Center Branch, at 101 W 8th Ave, Spokane, WA 99204. The practice phone is (509) 474-7370.

Rowena Inocencio's primary practice is Incyte Pathology - Sacred Heart Medical Center Branch in Spokane, Washington. Rowena Inocencio is also affiliated with Prov Sacred Hrt Med Ctr & Childs Hosp. The medical group on file is Providence Medical Group. Dmand AI also links Rowena Inocencio to 3 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Rowena Inocencio practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Rowena Inocencio's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Rowena Inocencio is licensed in Michigan.

CMS data shows 548 Medicare services from Rowena Inocencio across 4 procedure codes in 2024, for 224 Medicare patients. Medicare paid $38,960 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 224 Medicare patients who saw Rowena Inocencio in 2024. The largest group is 75 to 84, with 83 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 2.34, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Rowena Inocencio's median patient age at 74, with 46% women.

In 2024, Rowena Inocencio wrote 217 Medicare Part D claims for 102 patients. 91% of them were for generic drugs. CMS names the drug for 77 of them, across 6 drugs with 11 or more claims each, at $702 in total drug cost. In 2023, CMS named 25 claims across 2 drugs.

Rowena Inocencio accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 4 general payments to Rowena Inocencio from 3 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $250.